MISSISSAUGA, Ont. – Specialty drug maker Cipher Pharmaceuticals Inc. (TSX:DND) says its financial results were essentially flat in the third quarter with both its loss and revenue virtually unchanged ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback